Top analysts on stock perps · Analyst

Geulah Livshits (Chardan Capital): analyst track record on stock perps

Geulah Livshits of Chardan Capital on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.

Stars4.3★

Success37%

Excess return+9.6%

rank#1,627

Ratings491

ratings on stock perps14

Track record

TipRanks data via FMP

	12 months	3 years
Ratings	63	184
Stock	23	26
Buy / hold / sell	62 / 1 / 0	182 / 2 / 0
Upgrades / downgrades / initiations	0 / 0 / 1	0 / 1 / 7
Price targets hit / missed	6 / 56 (10%)	17 / 164 (9%)
Avg. return after a rating (TipRanks)	-48.5%	-53.1%
Best / worst call	+106.0% / -97.7%	+200.8% / -97.7%

After buy calls: median 21-day move +6.2% · vs S&P 500 +7.0% · targets hit within a year 0% (n = 12)

Current calls on stock perps

Stock	Call	Target	vs last close	Date
$IOVA Iovance Biotherapeutics, Inc.	Buy · Reiterated	$14.00	+72.0%	May 7, 2026

Recent ratings

May 7, 2026 $IOVA: Reiterated · Buy · $14.00 · article
Apr 10, 2026 $IOVA: Maintained · Buy · $16.00 · article
Feb 24, 2026 $IOVA: Maintained · Buy · $16.00 · article
Nov 6, 2025 $IOVA: Maintained · Buy · $17.00 · article
Oct 7, 2025 $MRNA: Reiterated · Hold · article
Aug 8, 2025 $IOVA: Maintained · Buy · $20.00 · article
May 9, 2025 $IOVA: Maintained · Buy · $25.00 · article
Mar 3, 2025 $IOVA: Maintained · Buy · $30.00 · article
Feb 19, 2024 $IOVA: Reiterated · Buy · $34.00 · article
Dec 27, 2023 $IOVA: Reiterated · Buy · $29.00 · article
Nov 8, 2023 $IOVA: Reiterated · Buy · $29.00 · article
Aug 16, 2023 $IOVA: Reiterated · Buy · $29.00 · article
Aug 9, 2023 $IOVA: Reiterated · Buy · $29.00 · article
Jul 10, 2023 $IOVA: Maintained · Buy · $29.00 · article

Geulah Livshits4.3★ · 37% success · +9.6% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.